Clinical Trials Logo

Seach Results for — “ptsd”

CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders - Doxazosin

CAP - Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders

The proposed study will examine the efficacy of doxazosin in the treatment of PTSD and alcohol use disorder or substance use disorders.

NCT02500602 — Posttraumatic Stress Disorder
Status: Completed
http://inclinicaltrials.com/posttraumatic-stress-disorder/NCT02500602/

Improving Implementation of Evidence Based PTSD Psychotherapy for Veterans in the Community

Improving Implementation of Evidence Based PTSD Psychotherapy for Veterans in the Community

To further increase the access of evidence based psychotherapies for Veterans with Posttraumatic Stress Disorder, we propose to offer training and intensive consultation to community-based providers in Cognitive Processing Therapy for Posttraumatic Stress Disorder. However, we believe that many clinicians may not implement Cognitive Processing Therapy or take advantage of consultation after initial training. For this reason, we propose to examine the effectiveness of an enhanced training method, which would add Motivational Interviewing to the standard Cognitive Processing Therapy training. Motivational Interviewing is a form of collaborative discussion for strengthening motivation and commitment to change. We hypothesize that augmenting the standard Cognitive Processing Therapy training with these techniques will reduce providers' reluctance to fully implement the interventions.

NCT02499432 — PTSD
Status: Completed
http://inclinicaltrials.com/ptsd/NCT02499432/

N-acetylcysteine in the Treatment of PTSD and Addiction - NAC

Glial Regulators for Treating Comorbid Posttraumatic Stress and Substance Abuse Disorders

Examine the effects of N-acetylcysteine on PTSD symptoms, craving and substance use in veterans with PTSD and comorbid substance use disorders.

NCT02499029 — PTSD
Status: Completed
http://inclinicaltrials.com/ptsd/NCT02499029/

Doxazosin for PTSD and Alcohol Use Disorder

Doxazosin in the Treatment of Co-occuring PTSD and Alcohol Use Disorder

The study will test the efficacy of doxazosin, a long-acting and selective alpha-1 adrenergic antagonist, as compared to placebo in reducing PTSD symptomatology and alcohol use severity.

NCT02492334 — Alcohol Use Disorder
Status: Completed
http://inclinicaltrials.com/alcohol-use-disorder/NCT02492334/

Neurofeedback Prevention For Early Stress Related Adversity - NFPES

Neurofeedback Preventive Intervention for PTSD: a Method to Strengthen Mental and Emotional Resilience

Exposure to life threatening, traumatic and stress inducing events in general is an inevitable part of military combat service . Among individuals exposed to a traumatic event, approximately 85-90 % will develop a stress response from which they will recover without need for any medical intervention whatsoever. However, roughly 10-15 % will continue to suffer from post-traumatic symptoms along with depression or anxiety disorders1, . The prominent symptoms of post - traumatic stress disorder (PTSD), consists of reliving the event via invasive and painful memories that include: images, thoughts or feelings, night terrors, and extreme emotional distress that arise when exposure to external or internal cues similar to or symbolizing aspects of the traumatic event. Following this distress, behavioral avoidance of situations that trigger unpleasant memories may develop. Such mental stress may lead to avoidance of social situations and hinder normal daily functioning in a variety of contexts2. The question arises as to what distinguishes between those who are exposed to a traumatic event and recover spontaneously and those who fail to resume daily life and develop PTSD. Attempts to find personality and environmental risk factors for the development of PTSD have yet to yield any unequivocal conclusions. This has lead the scientific community to look for neuro-physical risk factors as well . Furthermore, evidence that early diagnosis and treatment of the disorder helps reduce the severity of post-trauma symptoms -stresses the need for the accurate localization of neurological risk factors and new immediate and/or preventative interventions. The aim of the present project is to develop a brain oriented training method for early preventive interventions of PTSD.

NCT02477722 — Stress Disorders, Post-Traumatic
Status: Active, not recruiting
http://inclinicaltrials.com/stress-disorders-post-traumatic/NCT02477722/

The Effects of Oxytocin on Startle Hyperreactivity in Patients With AUD and PTSD - POP

The Effects of Oxytocin on Social Ability, Alcohol Approach Bias, and Startle Hyperreactivity in Veterans With Alcohol Use Disorder and Post Traumatic Stress Disorder

This study will investigate the effects of oxytocin on alcohol-related behaviors, social abilities, and physiological startle responses in healthy individuals and patients with posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) using a randomized, placebo-controlled, dose-tiered, between-subject study design. Specifically, the investigators will determine if intranasal administration of a single dose of the pro-social neuropeptide oxytocin decreases alcohol-related approach bias and cravings, enhances social abilities, and decreases physiological hyperactivity. The investigators will also determine the optimal dose to achieve these effects and will explore psychosocial predictors of responses to oxytocin. The proposed work has the potential to yield a novel pharmacological treatment for AUD and PTSD, both leading causes of disability in the US Military for which currently available treatments are inadequate.

NCT02469259 — Alcoholism
Status: Completed
http://inclinicaltrials.com/alcoholism/NCT02469259/

Transcranial Magnetic Stimulation (TMS) to Treat mTBI and PTSD

A Study of Bilateral Prefrontal Transcranial Magnetic Stimulation (TMS) to Treat the Symptoms of Mild TBI (mTBI) and PTSD

The overall objective of this project is to determine the efficacy and tolerability of TMS for mild Traumatic Brain Injury (mTBI) with PTSD symptoms and correlate treatment response with anatomical and biological factors unique to each service member (SM). Exploratory work will be done to look at the neuronal and biological changes that may occur over the course of TMS treatment.

NCT02458521 — Traumatic Brain Injury
Status: Recruiting
http://inclinicaltrials.com/traumatic-brain-injury/NCT02458521/

Stress Management Program for World Trade Center (WTC) Responders

Mind-Body Treatment for WTC Responders With Comorbid PTSD and Respiratory Illness

Many responders to the World Trade Center (WTC) disaster continue to experience significant mental and physical health problems. Two of the most common health problems, post-traumatic stress disorder (PTSD) symptoms and respiratory illness, often occur together. Mental health conditions, such as PTSD, make physical illnesses worse and interfere with treatment. The primary goal of this study is to test a mind-body treatment designed to reduce both PTSD and respiratory symptoms.

NCT02457780 — PTSD
Status: Completed
http://inclinicaltrials.com/ptsd/NCT02457780/

Cranial Electrotherapy Stimulation (CES) Therapy - CES

Cranial Electrotherapy Stimulation (CES) Therapy for PTSD and Anxiety in OEF/OIF Veterans With Mild TBI

The primary aim of this proposed study is to gather preliminary data for CES use in treating PTSD and anxiety symptoms in OEF/OIF Veterans with PTSD and a history of TBI.

NCT02453347 — Depression
Status: Completed
http://inclinicaltrials.com/depression/NCT02453347/

Sustaining and Improving Clinicians' Use of Evidence-Based Psychotherapy (EBP) for PTSD

A Comparison of the Effects of Internet-Based Strategies to Support Mental Health Clinicians' Use of an Effective Psychotherapy for Post Traumatic Stress Disorder (PTSD) in Mental Health Systems

The purpose of the study is to compare the impact of two strategies to sustain and improve the delivery of an evidence-based psychotherapy for PTSD, Cognitive Processing Therapy (CPT) in three different mental health systems. These approaches are based on two different theories of what is necessary to promote successful implementation. We will examine whether these strategies lead to improved patient outcomes, clinician skill, proportion of clients who receive CPT, and other outcomes that are relevant to the implementation of evidence-based psychosocial treatments. By examining these questions in 3 different mental health systems, we will also examine whether the implementation strategies yield different results in different systems.

NCT02449421 — Post Traumatic Stress Disorder
Status: Active, not recruiting
http://inclinicaltrials.com/post-traumatic-stress-disorder/NCT02449421/